Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Isaac Teitelbaum

Concepts (357)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Peritoneal Dialysis
55
2024
95
13.650
 Why?
Kidney Failure, Chronic
41
2023
546
7.380
 Why?
Peritonitis
21
2024
81
3.790
 Why?
Renal Dialysis
18
2022
423
2.440
 Why?
Dialysis Solutions
11
2023
22
1.790
 Why?
Kidney
8
2023
1383
1.170
 Why?
Peritoneum
6
2023
41
1.160
 Why?
Serum Albumin
3
2022
149
0.880
 Why?
Kidney Tubules, Collecting
12
1994
30
0.880
 Why?
Catheters, Indwelling
5
2019
80
0.730
 Why?
Peritoneal Dialysis, Continuous Ambulatory
6
2021
15
0.720
 Why?
Acute Kidney Injury
5
2023
791
0.670
 Why?
Staphylococcus capitis
1
2019
1
0.660
 Why?
Coagulase
1
2019
6
0.660
 Why?
Renal Insufficiency, Chronic
3
2015
567
0.650
 Why?
Renal Replacement Therapy
4
2023
87
0.630
 Why?
Catheter-Related Infections
1
2019
72
0.620
 Why?
Ferric Compounds
2
2022
46
0.610
 Why?
Sucrose
2
2022
103
0.610
 Why?
Quality of Health Care
2
2020
610
0.610
 Why?
Anti-Bacterial Agents
6
2024
1708
0.580
 Why?
Arginine Vasopressin
7
1997
42
0.570
 Why?
Kidney Transplantation
3
2012
670
0.570
 Why?
Hyperphosphatemia
3
2022
15
0.560
 Why?
Peritoneal Fibrosis
1
2017
1
0.540
 Why?
Humans
77
2024
129847
0.540
 Why?
Staphylococcal Infections
3
2019
391
0.530
 Why?
Kidney Function Tests
4
2020
152
0.520
 Why?
Uremia
2
2014
14
0.520
 Why?
Glucans
2
2015
34
0.500
 Why?
Patient-Centered Care
1
2020
508
0.480
 Why?
Therapeutics
1
2015
14
0.470
 Why?
Body Water
1
2015
20
0.470
 Why?
Kidney Medulla
10
1997
34
0.470
 Why?
Voriconazole
1
2015
20
0.470
 Why?
beta-Cyclodextrins
1
2015
27
0.470
 Why?
Phosphates
2
2022
181
0.450
 Why?
Catheterization
3
2016
176
0.440
 Why?
Antifungal Agents
1
2015
130
0.440
 Why?
Chelating Agents
1
2014
69
0.430
 Why?
Blood Pressure
1
2020
1736
0.410
 Why?
GTP-Binding Proteins
6
1995
158
0.400
 Why?
Hemodialysis Solutions
1
2012
3
0.390
 Why?
Type C Phospholipases
6
1992
74
0.390
 Why?
Acidosis
1
2013
89
0.380
 Why?
Kidney Diseases
4
2021
382
0.380
 Why?
Hemofiltration
2
2010
30
0.360
 Why?
Glucose
2
2015
1003
0.350
 Why?
Hirudins
1
2010
53
0.340
 Why?
Urea
4
2021
76
0.320
 Why?
Cyclic AMP
6
1995
238
0.320
 Why?
Creatinine
5
2020
490
0.320
 Why?
Protein Kinase C
5
1995
262
0.310
 Why?
Kidney Tubules
4
1990
114
0.310
 Why?
Heparin
1
2010
254
0.310
 Why?
Nutritional Status
4
2022
328
0.300
 Why?
Heart Diseases
1
2012
352
0.300
 Why?
Glomerular Filtration Rate
5
2023
711
0.290
 Why?
Drug Resistance, Bacterial
1
2009
175
0.290
 Why?
Hemodialysis, Home
4
2023
8
0.280
 Why?
Survivors
1
2010
464
0.260
 Why?
Peptide Fragments
1
2010
695
0.260
 Why?
Cardiac Surgical Procedures
1
2012
509
0.260
 Why?
Patient Selection
2
2020
660
0.250
 Why?
Postoperative Complications
3
2012
2481
0.250
 Why?
Scleroderma, Systemic
1
2007
114
0.250
 Why?
Calcium
4
2020
1212
0.250
 Why?
Hernia, Abdominal
1
2005
7
0.240
 Why?
Peritoneal Cavity
1
2005
31
0.240
 Why?
Prospective Studies
11
2023
7158
0.240
 Why?
Patient Participation
2
2020
414
0.230
 Why?
Phosphorus
3
2022
92
0.230
 Why?
Time Factors
6
2015
6550
0.230
 Why?
Liver Failure
1
2005
91
0.230
 Why?
Hemoglobins
2
2020
339
0.220
 Why?
Internationality
3
2020
150
0.220
 Why?
Liver Transplantation
2
2012
833
0.220
 Why?
Middle Aged
18
2023
31177
0.220
 Why?
Teicoplanin
1
2024
15
0.220
 Why?
Quality Improvement
2
2023
1112
0.210
 Why?
Quality of Life
5
2020
2695
0.210
 Why?
Blood Chemical Analysis
1
2003
97
0.200
 Why?
Practice Guidelines as Topic
3
2020
1514
0.200
 Why?
Device Removal
2
2019
136
0.190
 Why?
Phosphatidylinositols
3
1991
57
0.190
 Why?
Rats
13
2014
5487
0.190
 Why?
Contraindications, Procedure
1
2021
11
0.190
 Why?
Attitude of Health Personnel
2
2020
1106
0.190
 Why?
Goals
2
2020
163
0.190
 Why?
Nephrologists
1
2021
12
0.180
 Why?
Critical Illness
4
2023
759
0.180
 Why?
Male
23
2023
63759
0.180
 Why?
Organism Hydration Status
1
2020
10
0.180
 Why?
Superior Vena Cava Syndrome
1
2000
3
0.180
 Why?
Chylous Ascites
1
2000
6
0.170
 Why?
Risk Factors
7
2023
9801
0.170
 Why?
Treatment Outcome
9
2020
10241
0.170
 Why?
Liver Cirrhosis
1
2003
281
0.170
 Why?
Epidermal Growth Factor
6
1994
170
0.170
 Why?
Stress, Psychological
1
2009
1070
0.170
 Why?
Acid-Base Equilibrium
1
2020
27
0.170
 Why?
Blood Volume
1
2020
61
0.170
 Why?
Aged
13
2024
22107
0.170
 Why?
Female
22
2024
68829
0.160
 Why?
Patient Care Planning
1
2020
146
0.160
 Why?
Magnesium
1
2020
155
0.160
 Why?
Potassium
1
2020
144
0.160
 Why?
Patient Reported Outcome Measures
2
2020
374
0.160
 Why?
Physician Executives
1
2019
33
0.160
 Why?
Societies, Medical
2
2020
759
0.150
 Why?
Congresses as Topic
1
2020
216
0.150
 Why?
Dogs
2
2023
385
0.150
 Why?
Survival Rate
2
2020
1872
0.150
 Why?
Drug Combinations
2
2022
331
0.140
 Why?
Receptors, Vasopressin
2
1995
19
0.140
 Why?
Renal Insufficiency
1
2020
149
0.140
 Why?
Kidney Concentrating Ability
1
1997
3
0.140
 Why?
Patient Education as Topic
3
2018
743
0.140
 Why?
Risk Assessment
4
2016
3269
0.140
 Why?
Adult
18
2024
35634
0.140
 Why?
Data Collection
1
2020
653
0.140
 Why?
Adenylyl Cyclase Inhibitors
2
1994
6
0.140
 Why?
United States
7
2023
13913
0.140
 Why?
Adenylyl Cyclases
3
1993
83
0.140
 Why?
Proportional Hazards Models
3
2022
1199
0.130
 Why?
Survival Analysis
2
2015
1271
0.130
 Why?
Hormones
2
1994
140
0.120
 Why?
Models, Animal
1
2017
376
0.120
 Why?
Ultrafiltration
1
2015
28
0.120
 Why?
Epithelial-Mesenchymal Transition
1
2017
201
0.120
 Why?
Curriculum
1
2021
928
0.110
 Why?
Sodium
2
2015
205
0.110
 Why?
Kaplan-Meier Estimate
2
2015
851
0.110
 Why?
Lung Injury
1
2017
211
0.110
 Why?
Palliative Care
1
2020
706
0.110
 Why?
Gastrointestinal Absorption
1
2014
5
0.110
 Why?
Inflammation
3
2017
2748
0.110
 Why?
Diglycerides
2
1993
61
0.110
 Why?
Treatment Failure
1
2015
339
0.110
 Why?
Virulence Factors, Bordetella
2
1991
19
0.110
 Why?
Pertussis Toxin
2
1991
26
0.110
 Why?
Animals
17
2023
35409
0.110
 Why?
Biological Transport
1
2015
405
0.110
 Why?
Biomedical Research
1
2020
640
0.110
 Why?
Didanosine
1
1993
13
0.110
 Why?
Phospholipases A
2
1992
99
0.110
 Why?
Anti-Infective Agents
1
2016
249
0.110
 Why?
Cytosol
1
1994
219
0.100
 Why?
HIV Seropositivity
1
1993
120
0.100
 Why?
Oleanolic Acid
1
2012
9
0.100
 Why?
Methylene Blue
1
2012
23
0.100
 Why?
Equipment Design
2
2014
514
0.100
 Why?
Tissue Adhesions
1
2012
30
0.100
 Why?
Vascular Calcification
1
2014
107
0.100
 Why?
Delayed Graft Function
1
2012
30
0.100
 Why?
Prognosis
4
2016
3773
0.100
 Why?
Hematinics
1
2012
20
0.100
 Why?
Cells, Cultured
9
1994
4102
0.090
 Why?
Vasoconstrictor Agents
1
2012
127
0.090
 Why?
Receptors, Angiotensin
1
1991
12
0.090
 Why?
Retrospective Studies
6
2023
14553
0.090
 Why?
Nephrectomy
1
2012
158
0.090
 Why?
Transplantation, Homologous
1
2012
402
0.090
 Why?
Atrial Natriuretic Factor
1
1991
56
0.090
 Why?
Bacterial Infections
2
2003
234
0.090
 Why?
Hypotension
1
2012
117
0.090
 Why?
Practice Patterns, Physicians'
1
2020
1274
0.090
 Why?
Restless Legs Syndrome
1
2011
21
0.090
 Why?
Glycerides
1
1990
20
0.090
 Why?
Aluminum Compounds
1
1990
6
0.080
 Why?
Phospholipases
1
1990
13
0.080
 Why?
Antithrombins
1
2010
58
0.080
 Why?
Follow-Up Studies
4
2011
4896
0.080
 Why?
Membranes, Artificial
1
2010
71
0.080
 Why?
Models, Biological
1
2017
1724
0.080
 Why?
Virginiamycin
1
2009
3
0.080
 Why?
Double-Blind Method
2
2012
1877
0.080
 Why?
Linezolid
1
2009
20
0.080
 Why?
Daptomycin
1
2009
19
0.080
 Why?
Graft Survival
1
2012
514
0.080
 Why?
Oxazolidinones
1
2009
15
0.080
 Why?
Minerals
1
2009
40
0.080
 Why?
Acetamides
1
2009
36
0.080
 Why?
Protein Kinases
1
1991
318
0.080
 Why?
Infection Control
1
2010
143
0.080
 Why?
Enzyme Inhibitors
1
2012
827
0.080
 Why?
Antibiotic Prophylaxis
2
2022
102
0.070
 Why?
Hematuria
1
1988
12
0.070
 Why?
Aged, 80 and over
1
2019
7066
0.070
 Why?
Communicable Diseases
1
2010
152
0.070
 Why?
Sympathetic Nervous System
1
1989
174
0.070
 Why?
Hepatorenal Syndrome
1
2007
14
0.070
 Why?
RNA, Messenger
1
1995
2703
0.070
 Why?
Enzyme Activation
4
1994
813
0.070
 Why?
Kidney Tubular Necrosis, Acute
1
2007
26
0.070
 Why?
Sleep Wake Disorders
1
2011
255
0.070
 Why?
Proteinuria
1
1988
91
0.070
 Why?
Recombinant Proteins
1
2010
1311
0.070
 Why?
Tetradecanoylphorbol Acetate
3
1993
149
0.070
 Why?
Spondylitis, Ankylosing
1
1988
46
0.070
 Why?
Primary Prevention
2
2016
190
0.070
 Why?
Inositol Phosphates
3
1991
23
0.070
 Why?
ErbB Receptors
1
1990
605
0.070
 Why?
Biopsy, Needle
1
2007
187
0.060
 Why?
Anticoagulants
1
2010
637
0.060
 Why?
Incidence
3
2007
2646
0.060
 Why?
Hemodialysis Units, Hospital
1
2005
5
0.060
 Why?
Nephrology
2
2020
60
0.060
 Why?
Imipenem
1
2005
18
0.060
 Why?
Ethics, Clinical
1
2005
7
0.060
 Why?
Kinetics
3
2017
1645
0.060
 Why?
Skin Diseases
1
2007
143
0.060
 Why?
Vasculitis
1
2005
65
0.060
 Why?
Staphylococcus aureus
1
2009
436
0.060
 Why?
Capillaries
1
2005
103
0.060
 Why?
Health Services Accessibility
1
2011
903
0.060
 Why?
Medication Adherence
1
2009
561
0.060
 Why?
Canada
1
2005
353
0.060
 Why?
Fibrosis
1
2007
526
0.060
 Why?
Gastric Acid
1
2023
14
0.050
 Why?
Bromcresol Green
1
2003
1
0.050
 Why?
Bromcresol Purple
1
2003
1
0.050
 Why?
Combined Modality Therapy
1
2007
1201
0.050
 Why?
Nephelometry and Turbidimetry
1
2003
13
0.050
 Why?
Hepcidins
1
2023
22
0.050
 Why?
Disease Models, Animal
1
2014
4077
0.050
 Why?
Indicators and Reagents
1
2003
109
0.050
 Why?
Permeability
1
2003
158
0.050
 Why?
Triglycerides
1
2006
528
0.050
 Why?
Drug Resistance
2
2012
165
0.050
 Why?
Equipment Failure
1
2003
106
0.050
 Why?
Eosinophils
1
2006
324
0.050
 Why?
Vancomycin
1
2024
78
0.050
 Why?
Severity of Illness Index
2
2011
2739
0.050
 Why?
Inositol 1,4,5-Trisphosphate
2
1994
31
0.050
 Why?
Burns
1
2007
292
0.050
 Why?
Monocytes
1
2006
554
0.050
 Why?
Lung Transplantation
1
2005
290
0.050
 Why?
Regression Analysis
1
2005
998
0.050
 Why?
Medicare
2
2022
719
0.050
 Why?
Cats
1
2023
207
0.050
 Why?
Hypoalbuminemia
1
2022
30
0.050
 Why?
Cohort Studies
4
2020
5444
0.050
 Why?
Ownership
1
2023
87
0.050
 Why?
Patient Compliance
1
2006
568
0.050
 Why?
Phospholipases A2
2
1992
79
0.050
 Why?
Positron-Emission Tomography
1
2023
282
0.050
 Why?
Guanosine 5'-O-(3-Thiotriphosphate)
2
1991
14
0.040
 Why?
Guanosine Diphosphate
2
1991
20
0.040
 Why?
Thionucleotides
2
1991
34
0.040
 Why?
Erythrocytes
1
2006
673
0.040
 Why?
Recurrence
1
2003
1013
0.040
 Why?
Dinoprostone
2
1990
187
0.040
 Why?
Chronic Disease
1
2005
1724
0.040
 Why?
Child
3
2013
20962
0.040
 Why?
Terminology as Topic
1
2020
204
0.040
 Why?
Potassium, Dietary
1
1998
11
0.040
 Why?
Predictive Value of Tests
2
2017
1951
0.040
 Why?
Drinking
1
1998
40
0.040
 Why?
Sodium, Dietary
1
1998
37
0.040
 Why?
Hyponatremia
1
1998
40
0.040
 Why?
Cardiovascular Diseases
1
2010
2008
0.040
 Why?
Diabetes Mellitus, Type 2
1
2012
2444
0.040
 Why?
Pilot Projects
1
2022
1597
0.030
 Why?
Diabetic Nephropathies
1
2000
284
0.030
 Why?
Quality Control
1
2017
162
0.030
 Why?
Hospitalization
1
2006
2079
0.030
 Why?
Dose-Response Relationship, Drug
2
1991
2016
0.030
 Why?
Fluid Therapy
1
2017
133
0.030
 Why?
Reproducibility of Results
1
2003
3089
0.030
 Why?
Prostaglandins
1
1995
94
0.030
 Why?
Quality Indicators, Health Care
1
2017
298
0.030
 Why?
Ionomycin
1
1994
25
0.030
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1994
182
0.030
 Why?
Isoproterenol
1
1994
116
0.030
 Why?
Prevalence
2
2011
2564
0.030
 Why?
Colforsin
1
1993
50
0.030
 Why?
Interleukin-6
1
2017
724
0.030
 Why?
Guanylate Cyclase
1
1992
35
0.030
 Why?
Shock, Surgical
1
2012
2
0.020
 Why?
Intraoperative Care
1
2012
46
0.020
 Why?
Catecholamines
1
2012
96
0.020
 Why?
Sample Size
1
2012
116
0.020
 Why?
Poisson Distribution
1
2012
73
0.020
 Why?
Prospective Payment System
1
2011
13
0.020
 Why?
Base Sequence
1
1995
2142
0.020
 Why?
Total Quality Management
1
2011
60
0.020
 Why?
Inositol
1
1991
26
0.020
 Why?
Accreditation
1
2011
80
0.020
 Why?
Receptors, Oxytocin
1
1991
22
0.020
 Why?
Cyclic GMP
1
1991
90
0.020
 Why?
Dideoxyadenosine
1
1990
1
0.020
 Why?
Oxytocin
1
1991
47
0.020
 Why?
Molecular Sequence Data
1
1995
2833
0.020
 Why?
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
1
1990
28
0.020
 Why?
Adenosine Diphosphate Ribose
1
1990
7
0.020
 Why?
Isoquinolines
1
1990
42
0.020
 Why?
Fluorides
1
1990
50
0.020
 Why?
Aluminum
1
1990
39
0.020
 Why?
Guanosine Triphosphate
1
1990
92
0.020
 Why?
Hydrolysis
1
1990
186
0.020
 Why?
Rats, Sprague-Dawley
1
1995
2403
0.020
 Why?
Adrenergic alpha-Agonists
1
1989
28
0.020
 Why?
Adrenergic alpha-Antagonists
1
1989
33
0.020
 Why?
Health Surveys
1
2011
495
0.020
 Why?
Analysis of Variance
1
2012
1291
0.020
 Why?
Rats, Inbred Strains
1
1989
368
0.020
 Why?
In Vitro Techniques
1
1990
1092
0.020
 Why?
Adrenergic beta-Agonists
1
1989
133
0.020
 Why?
Glomerulonephritis, IGA
1
1988
10
0.020
 Why?
Piperazines
1
1990
339
0.020
 Why?
Clinical Trials as Topic
1
2012
1005
0.020
 Why?
Cost of Illness
1
2009
277
0.020
 Why?
Adrenergic beta-Antagonists
1
1989
321
0.020
 Why?
Morbidity
1
2007
302
0.020
 Why?
Research Design
1
2012
1045
0.020
 Why?
Biomarkers
1
2017
3971
0.020
 Why?
Cilastatin
1
2005
2
0.020
 Why?
Healthcare Disparities
1
2012
580
0.020
 Why?
Hemodiafiltration
1
2005
9
0.020
 Why?
Multivariate Analysis
1
2009
1501
0.010
 Why?
Telemedicine
1
2014
792
0.010
 Why?
Osmolar Concentration
2
1998
167
0.010
 Why?
Protease Inhibitors
1
2005
107
0.010
 Why?
Sensitivity and Specificity
1
2009
1847
0.010
 Why?
Protein Kinase Inhibitors
1
1990
886
0.010
 Why?
Comorbidity
1
2009
1551
0.010
 Why?
Biopsy
1
1988
1089
0.010
 Why?
Acute Disease
1
2007
980
0.010
 Why?
Respiratory Function Tests
1
2005
581
0.010
 Why?
Drug Therapy, Combination
1
2005
1042
0.010
 Why?
Graft Rejection
1
2005
598
0.010
 Why?
Colorado
1
1990
4410
0.010
 Why?
Immunosuppressive Agents
1
2005
858
0.010
 Why?
Mice
1
2017
16983
0.010
 Why?
Lung Diseases
1
2005
743
0.010
 Why?
Beer
1
1998
7
0.010
 Why?
Diet, Vegetarian
1
1998
8
0.010
 Why?
Urine
1
1998
60
0.010
 Why?
Cross-Sectional Studies
1
2009
5085
0.010
 Why?
Dietary Proteins
1
1998
129
0.010
 Why?
Signal Transduction
1
1990
4935
0.010
 Why?
Muscarine
1
1994
3
0.010
 Why?
Carbachol
1
1994
20
0.010
 Why?
Vasopressins
1
1994
64
0.010
 Why?
Tyrosine
1
1994
223
0.010
 Why?
Cell Polarity
1
1994
139
0.010
 Why?
Purines
1
1994
172
0.010
 Why?
Adolescent
1
2012
20451
0.010
 Why?
Lung
1
2005
3940
0.010
 Why?
Hypertonic Solutions
1
1991
7
0.010
 Why?
Nocodazole
1
1991
16
0.010
 Why?
Cycloheximide
1
1991
55
0.010
 Why?
Isotonic Solutions
1
1991
37
0.010
 Why?
Culture Media
1
1991
162
0.010
 Why?
Phosphorylation
1
1994
1716
0.010
 Why?
Peptides
1
1994
926
0.000
 Why?
Teitelbaum's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (357) concept(s)
_
Co-Authors Expand Description
See all (21) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)